Back

Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?

European Heart Journal

23 May 2021
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Jan Gerrit van der Stouwe
Jan Gerrit van der Stouwe

Author

University Hospital Basel Basel , Switzerland

Jasper Boeddinghaus
Jasper Boeddinghaus

Author

Christian Mueller
Christian Mueller

Author

You may be interested in
thumbnail
Congress Presentation
The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study
26 August 2023
thumbnail
Congress Presentation
Clinical application of the fourth universal definition of myocardial infarction
2 September 2019
thumbnail
Congress Presentation
Tends in beta-blocker administration and in prevalence of indications for their usage in heart failure with preserved ejection fraction: an analysis of randomized clinical trials
27 August 2021
thumbnail
Congress Presentation
Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources